Vaxart, Inc. (VXRT) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $16.97M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $16.97M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $16.97M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | $872.00K | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. $872.00K − $0.00 ≈ $872.00K |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 82.81M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 16.97M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability · Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | 1.52M USD | Deferred Revenue, Noncurrent · Contract with Customer, Liability · Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 872.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | 0.00 USD | Contract with Customer, Liability · Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- $872.00K
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $7.81M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $16.97M | (m) | (m) | $872.00K | $82.81M | (m) | (m) | $1.52M | $872.00K | $0.00 |
| 2026-03-31 | (m) | $24.18M | (m) | (m) | (m) | $85.94M | (m) | (m) | (m) | $841.00K | (m) |
| 2025-12-31 | (m) | $21.50M | (m) | (m) | (m) | $98.28M | (m) | (m) | (m) | $817.00K | (m) |
| 2025-09-30 | (m) | $53.08M | (m) | (m) | (m) | $182.23M | (m) | (m) | (m) | $489.00K | (m) |
| 2025-06-30 | (m) | $10.61M | (m) | (m) | (m) | $131.21M | (m) | (m) | (m) | $472.00K | (m) |
| 2025-03-31 | (m) | $16.62M | (m) | (m) | (m) | $112.94M | (m) | (m) | (m) | $455.00K | (m) |
| 2024-12-31 | (m) | $6.96M | (m) | (m) | (m) | $107.46M | (m) | (m) | (m) | $439.00K | (m) |
| 2024-09-30 | (m) | $2.52M | (m) | (m) | (m) | $98.23M | (m) | (m) | (m) | $421.00K | (m) |
| 2024-06-30 | (m) | $3.59M | (m) | (m) | (m) | $33.73M | (m) | (m) | (m) | $405.00K | (m) |
| 2024-03-31 | (m) | $3.98M | (m) | (m) | (m) | $32.98M | (m) | (m) | (m) | $309.00K | (m) |
| 2023-12-31 | (m) | $1.58M | (m) | (m) | (m) | $34.02M | (m) | $0.00 | (m) | $293.00K | (m) |
| 2023-09-30 | (m) | $1.34M | (m) | (m) | (m) | $34.12M | (m) | $79.00K | (m) | $278.00K | (m) |
| 2023-06-30 | (m) | $4.20M | (m) | (m) | (m) | $37.58M | (m) | $275.00K | (m) | $262.00K | (m) |
| 2023-03-31 | (m) | $3.88M | (m) | (m) | (m) | $40.10M | (m) | $1.60M | (m) | $246.00K | (m) |
| 2022-12-31 | (m) | $5.51M | (m) | (m) | (m) | $43.25M | (m) | $2.00M | (m) | $231.00K | (m) |
| 2022-09-30 | (m) | $7.92M | (m) | (m) | (m) | $53.00M | (m) | (m) | (m) | $216.00K | (m) |
| 2022-06-30 | (m) | $5.01M | (m) | (m) | (m) | $38.36M | (m) | (m) | (m) | $201.00K | (m) |
| 2022-03-31 | (m) | $4.02M | (m) | (m) | (m) | $34.01M | (m) | (m) | (m) | $186.00K | (m) |
| 2021-12-31 | (m) | $3.87M | $0.00 | (m) | (m) | $33.64M | (m) | (m) | (m) | $171.00K | (m) |
| 2021-09-30 | (m) | $3.75M | $0.00 | (m) | (m) | $36.19M | (m) | (m) | (m) | $156.00K | (m) |
| 2021-06-30 | (m) | $3.70M | $0.00 | (m) | (m) | $29.06M | (m) | (m) | (m) | $142.00K | (m) |
| 2021-03-31 | (m) | $4.64M | $0.00 | (m) | (m) | $29.63M | (m) | (m) | (m) | $122.00K | (m) |
| 2020-12-31 | (m) | $2.13M | $0.00 | (m) | (m) | $29.18M | (m) | (m) | (m) | $109.00K | (m) |
| 2020-09-30 | (m) | $1.87M | $0.00 | (m) | (m) | $23.03M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $1.17M | $0.00 | (m) | (m) | $23.95M | (m) | (m) | (m) | $18.00K | (m) |
| 2020-03-31 | (m) | $793.00K | $0.00 | (m) | (m) | $21.27M | (m) | (m) | (m) | $18.00K | (m) |
| 2019-12-31 | (m) | $852.00K | $0.00 | (m) | (m) | $24.08M | (m) | (m) | (m) | $18.00K | (m) |
| 2019-09-30 | (m) | $1.05M | (m) | (m) | (m) | $23.79M | (m) | $110.00K | (m) | $18.00K | (m) |
| 2019-06-30 | (m) | $610.00K | (m) | (m) | (m) | $21.41M | (m) | (m) | (m) | $18.00K | (m) |
| 2019-03-31 | (m) | $849.00K | (m) | (m) | (m) | $23.73M | (m) | (m) | (m) | $18.00K | (m) |
| 2018-12-31 | (m) | $962.00K | $17.74M | (m) | $157.00K | $23.99M | (m) | $3.33M | $14.41M | $157.00K | $0.00 |
| 2018-09-30 | (m) | $1.30M | $17.58M | (m) | (m) | $24.65M | (m) | $3.28M | $14.30M | (m) | $0.00 |
| 2018-06-30 | (m) | $1.45M | $17.07M | (m) | (m) | $25.41M | (m) | $3.15M | $13.92M | (m) | $0.00 |
| 2018-03-31 | (m) | $1.74M | $16.60M | (m) | (m) | $25.43M | (m) | $2.04M | $14.56M | (m) | $0.00 |
| 2017-12-31 | (m) | $1.70M | $17.20M | (m) | $100.00K | $21.80M | (m) | $1.20M | $16.00M | $100.00K | $0.00 |
| 2017-09-30 | (m) | $1.30M | $16.90M | (m) | $100.00K | $20.80M | (m) | $1.50M | $15.40M | $100.00K | $0.00 |
| 2017-06-30 | (m) | $1.40M | $16.70M | (m) | $100.00K | $21.40M | (m) | $1.40M | $15.30M | $100.00K | $0.00 |
| 2017-03-31 | (m) | $1.80M | $17.10M | (m) | $200.00K | $22.50M | (m) | $400.00K | $16.70M | $200.00K | $0.00 |
| 2016-12-31 | (m) | $3.40M | $18.80M | (m) | $200.00K | $28.50M | (m) | $1.20M | $17.60M | $200.00K | $0.00 |
| 2016-09-30 | (m) | $1.60M | $18.40M | (m) | $200.00K | $26.50M | (m) | $1.20M | $17.20M | $200.00K | $0.00 |
| 2016-06-30 | (m) | $3.90M | $18.10M | (m) | $200.00K | $26.50M | (m) | $1.30M | $16.80M | $200.00K | $0.00 |
| 2016-03-31 | (m) | $3.70M | (m) | (m) | (m) | $9.20M | (m) | (m) | (m) | $200.00K | (m) |
| 2015-12-31 | (m) | $1.30M | (m) | (m) | (m) | $6.70M | (m) | (m) | (m) | $200.00K | (m) |
| 2015-09-30 | (m) | $2.90M | (m) | (m) | (m) | $7.50M | (m) | (m) | (m) | $100.00K | (m) |
| 2015-06-30 | (m) | $1.90M | (m) | (m) | (m) | $9.90M | (m) | (m) | (m) | $100.00K | (m) |
| 2015-03-31 | (m) | $1.00M | (m) | (m) | (m) | $7.30M | (m) | (m) | (m) | $100.00K | (m) |
| 2014-12-31 | (m) | $1.70M | (m) | (m) | (m) | $11.00M | (m) | (m) | (m) | $100.00K | (m) |
| 2014-09-30 | (m) | $1.40M | (m) | (m) | (m) | $19.40M | (m) | (m) | (m) | $100.00K | (m) |
| 2014-06-30 | (m) | $2.80M | (m) | (m) | (m) | $27.10M | (m) | (m) | (m) | $200.00K | (m) |
| 2014-03-31 | (m) | $7.30M | (m) | (m) | (m) | $24.50M | (m) | (m) | (m) | $200.00K | (m) |
| 2013-12-31 | (m) | $9.60M | (m) | (m) | (m) | $18.50M | (m) | (m) | (m) | $200.00K | (m) |
| 2013-09-30 | (m) | $2.10M | (m) | (m) | (m) | $14.10M | (m) | $100.00K | (m) | $300.00K | (m) |
| 2013-06-30 | (m) | $4.40M | (m) | (m) | (m) | $16.10M | (m) | $300.00K | (m) | $200.00K | (m) |
| 2013-03-31 | (m) | $2.28M | (m) | (m) | (m) | $14.73M | (m) | $650.00K | (m) | $296.00K | (m) |
| 2012-12-31 | (m) | $4.47M | (m) | (m) | (m) | $17.22M | (m) | $881.00K | (m) | $275.00K | (m) |
| 2012-09-30 | (m) | $333.00K | $33.47M | (m) | (m) | $36.54M | (m) | $2.53M | $30.95M | (m) | $0.00 |
| 2012-06-30 | (m) | $75.00K | $34.10M | (m) | (m) | $35.62M | (m) | $2.53M | $31.58M | (m) | $0.00 |
| 2012-03-31 | (m) | $69.00K | $34.74M | (m) | (m) | $35.83M | (m) | $2.53M | $32.21M | (m) | $0.00 |
| 2011-12-31 | (m) | $146.00K | $35.37M | (m) | (m) | $39.09M | (m) | $2.53M | $32.84M | (m) | $0.00 |
| 2011-09-24 | (m) | $983.00K | $36.00M | (m) | (m) | $43.36M | (m) | $2.53M | $33.47M | (m) | $0.00 |
| 2011-06-25 | (m) | $1.19M | $36.63M | (m) | (m) | $45.64M | (m) | $2.53M | $34.11M | (m) | $0.00 |
| 2010-12-25 | (m) | $552.00K | $43.16M | (m) | (m) | $53.30M | (m) | $7.80M | $35.37M | (m) | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |